Literature DB >> 21833587

Deletion of platelet-derived growth factor receptor-β improves diabetic nephropathy in Ca²⁺/calmodulin-dependent protein kinase IIα (Thr286Asp) transgenic mice.

H Suzuki1, I Usui, I Kato, T Oya, Y Kanatani, Y Yamazaki, S Fujisaka, S Senda, Y Ishii, M Urakaze, A Mahmood, S Takasawa, H Okamoto, M Kobayashi, K Tobe, M Sasahara.   

Abstract

AIMS/HYPOTHESIS: The activation of platelet-derived growth factor receptor-β (PDGFR-β) signalling is increased in the glomeruli and tubules of diabetic animals. In this study, we examined the role of PDGFR-β signalling during the development of diabetic nephropathy.
METHODS: We recently generated pancreatic beta cell-specific Ca(2+)/calmodulin-dependent protein kinase IIα (Thr286Asp) transgenic mice (CaMKIIα mice), which show very high plasma glucose levels up to 55.5 mmol/l and exhibit the features of diabetic nephropathy. These mice were crossed with conditional knockout mice in which Pdgfr-β (also known as Pdgfrb) was deleted postnatally. The effect of the deletion of the Pdgfr-β gene on diabetic nephropathy in CaMKIIα mice was evaluated at 10 and 16 weeks of age.
RESULTS: The plasma glucose concentrations and HbA(1c) levels were elevated in the CaMKIIα mice from 4 weeks of age. Variables indicative of diabetic nephropathy, such as an increased urinary albumin/creatinine ratio, kidney weight/body weight ratio and mesangial area/glomerular area ratio, were observed at 16 weeks of age. The postnatal deletion of the Pdgfr-β gene significantly decreased the urinary albumin/creatinine ratio and mesangial area/glomerular area ratio without affecting the plasma glucose concentration. Furthermore, the increased oxidative stress in the kidneys of the CaMKIIα mice as shown by the increased urinary 8-hydroxydeoxyguanosine (8-OHdG) excretion and the increased expression of NAD(P)H oxidase 4 (NOX4), glutathione peroxidase 1 (GPX1) and manganese superoxide dismutase (MnSOD) was decreased by Pdgfr-β gene deletion. CONCLUSIONS/
INTERPRETATION: The activation of PDGFR-β signalling contributes to the progress of diabetic nephropathy, with an increase in oxidative stress and mesangial expansion in CaMKIIα mice.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21833587     DOI: 10.1007/s00125-011-2270-x

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  47 in total

Review 1.  Potential utility of small tyrosine kinase inhibitors in the treatment of diabetes.

Authors:  Dariush Mokhtari; Nils Welsh
Journal:  Clin Sci (Lond)       Date:  2009-11-09       Impact factor: 6.124

2.  Mouse brains deficient in neuronal PDGF receptor-beta develop normally but are vulnerable to injury.

Authors:  Yoko Ishii; Takeshi Oya; Lianshun Zheng; Zhiyang Gao; Makoto Kawaguchi; Hemragul Sabit; Takako Matsushima; Ayano Tokunaga; Shin Ishizawa; Etsuro Hori; Yo-ichi Nabeshima; Toshikuni Sasaoka; Toshihiko Fujimori; Hisashi Mori; Masakiyo Sasahara
Journal:  J Neurochem       Date:  2006-07       Impact factor: 5.372

3.  Immunohistochemical characterization of glomerular PDGF B-chain and PDGF beta-receptor expression in diabetic rats.

Authors:  H Nakagawa; M Sasahara; M Haneda; D Koya; F Hazama; R Kikkawa
Journal:  Diabetes Res Clin Pract       Date:  2000-05       Impact factor: 5.602

4.  Gene expression of PDGF and PDGF receptor in various forms of glomerulonephritis.

Authors:  M Matsuda; K Shikata; H Makino; H Sugimoto; K Ota; K Akiyama; K Hirata; Z Ota
Journal:  Am J Nephrol       Date:  1997       Impact factor: 3.754

5.  PDGF receptor-alpha deficiency in glomerular mesangial cells of tenascin-C knockout mice.

Authors:  Kenji Matsumoto; Noriko Hiraiwa; Atsushi Yoshiki; Masatake Ohnishi; Moriaki Kusakabe
Journal:  Biochem Biophys Res Commun       Date:  2002-02-01       Impact factor: 3.575

Review 6.  Renal fibrosis: new insights into the pathogenesis and therapeutics.

Authors:  Youhua Liu
Journal:  Kidney Int       Date:  2006-01       Impact factor: 10.612

7.  Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study.

Authors:  M Krolewski; P W Eggers; J H Warram
Journal:  Kidney Int       Date:  1996-12       Impact factor: 10.612

8.  Pitavastatin ameliorates albuminuria and renal mesangial expansion by downregulating NOX4 in db/db mice.

Authors:  M Fujii; T Inoguchi; Y Maeda; S Sasaki; F Sawada; R Saito; K Kobayashi; H Sumimoto; R Takayanagi
Journal:  Kidney Int       Date:  2007-06-13       Impact factor: 10.612

9.  Antagonism of PDGF-D by human antibody CR002 prevents renal scarring in experimental glomerulonephritis.

Authors:  Tammo Ostendorf; Song Rong; Peter Boor; Stefanie Wiedemann; Uta Kunter; Ulrike Haubold; Claudia R C van Roeyen; Frank Eitner; Hiroshi Kawachi; Gary Starling; Enrique Alvarez; Glennda Smithson; Jürgen Floege
Journal:  J Am Soc Nephrol       Date:  2006-03-01       Impact factor: 10.121

Review 10.  Multiple roles for platelet-derived growth factor in renal disease.

Authors:  J Floege; R J Johnson
Journal:  Miner Electrolyte Metab       Date:  1995
View more
  9 in total

Review 1.  Targeting CTGF, EGF and PDGF pathways to prevent progression of kidney disease.

Authors:  Helena M Kok; Lucas L Falke; Roel Goldschmeding; Tri Q Nguyen
Journal:  Nat Rev Nephrol       Date:  2014-10-14       Impact factor: 28.314

Review 2.  Targeting the progression of chronic kidney disease.

Authors:  Marta Ruiz-Ortega; Sandra Rayego-Mateos; Santiago Lamas; Alberto Ortiz; Raul R Rodrigues-Diez
Journal:  Nat Rev Nephrol       Date:  2020-02-14       Impact factor: 28.314

Review 3.  Nox4 and diabetic nephropathy: with a friend like this, who needs enemies?

Authors:  Yves Gorin; Karen Block
Journal:  Free Radic Biol Med       Date:  2013-03-23       Impact factor: 7.376

Review 4.  VEGF and podocytes in diabetic nephropathy.

Authors:  Alda Tufro; Delma Veron
Journal:  Semin Nephrol       Date:  2012-07       Impact factor: 5.299

5.  Semaphorin3a promotes advanced diabetic nephropathy.

Authors:  Pardeep K Aggarwal; Delma Veron; David B Thomas; Dionicio Siegel; Gilbert Moeckel; Michael Kashgarian; Alda Tufro
Journal:  Diabetes       Date:  2014-12-04       Impact factor: 9.461

6.  Osteomeles schwerinae Extract Prevents Diabetes-Induced Renal Injury in Spontaneously Diabetic Torii Rats.

Authors:  Eunjin Sohn; Junghyun Kim; Chan-Sik Kim; Kyuhyung Jo; Jin Sook Kim
Journal:  Evid Based Complement Alternat Med       Date:  2018-04-24       Impact factor: 2.629

7.  Hepatotoxicity Induced by Sophora flavescens and Hepatic Accumulation of Kurarinone, a Major Hepatotoxic Constituent of Sophora flavescens in Rats.

Authors:  Peng Jiang; Xiuwen Zhang; Yutong Huang; Nengneng Cheng; Yueming Ma
Journal:  Molecules       Date:  2017-10-25       Impact factor: 4.411

Review 8.  The Role of Platelets in Diabetic Kidney Disease.

Authors:  Ukhti Jamil Rustiasari; Joris J Roelofs
Journal:  Int J Mol Sci       Date:  2022-07-27       Impact factor: 6.208

9.  Renal Protective Role of Xiexin Decoction with Multiple Active Ingredients Involves Inhibition of Inflammation through Downregulation of the Nuclear Factor-κB Pathway in Diabetic Rats.

Authors:  Jia-Sheng Wu; Rong Shi; Jie Zhong; Xiong Lu; Bing-Liang Ma; Tian-Ming Wang; Bin Zan; Yue-Ming Ma; Neng-Neng Cheng; Fu-Rong Qiu
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-02       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.